PEBP1 and hepatocellular carcinoma: RKIP expression is significantly decreased in insulinomas [24], anaplastic thyroid tumors [25], cutaneous squamous cell carcinoma [26], endometrial cancer [27], and hepatocellular carcinoma [28].